Impact of Adapted Aesthetic Onco in Patients With Upper Aerodigestive Tract Cancer During Their Management
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorCentre Francois Baclesse
About this trial
Treatment for cancers of the pharyngolarynx is mutilating, with major consequences for patients' lives in terms of physical and functional after-effects. The psycho-social consequences are also significant, notably the metamorphosis of identity linked to the disease and its treatment, which alters the patient's self-image.
Initial feedback from patients who have been able to benefit from adapted oncoesthetics (OEA) is overwhelmingly positive.
This study will assess the feasibility of oncoesthetics and describe any obstacles.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patient aged 18 or over
Neoplastic location: oropharynx, oral cavity, hypopharynx, larynx, nasal cavity, salivary glands, cavum, sinus.
Patient due to start oncological treatment (recurrence authorized)
Patient fluent in French.
Disqualifiers
Breast-feeding or pregnant patient
Any associated medical or psychological condition that could compromise the patient's ability to participate in the study
Patient deprived of liberty, under guardianship, or subject to a legal protection measure or unable to express their consent.
Patient unable to undergo trial follow-up for geographical, social or psychopathological reasons.
Trial design
Design model
Single group
Treatments tested in this trial
Adapted Onco-Esthetics sessions
Other interventionPatient will received three sessions of Adapted Onco-Esthetics
Treatment groups
55 Participants
are divided into 1 treatment groupGroup A: Three sessions of Adapted Onco-EstheticsExperimental treatment 1 intervention
Trial outcomes
Primary outcomes
1
Evaluate, in patients treated for cancer of the upper aerodigestive tract, the impact of early treatment with Adapted Onco-Esthetics
Evaluation of the proportion of patients reporting no worsening of self-image representation, as measured by the BIS body image scale.
Time frame
At each session (first , second and third). An interval of one to 4 weeks between 2 sessions is permittedSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov